Characteristic | |
---|---|
Mean age (years) (SD) | 39 (8.7) |
Sex | |
Male, n (%) | 30 (63.8)* |
HIV infection & Antiretroviral treatment | |
Median nadir CD4 count (cells/μL) (IQR) | 153 (85–247) |
Median CD4 count at the time of evaluation (cells/μL) (IQR) | 264 (158–361) |
HIV viral load undetectable (<20 copies/μL) at the time of evaluation, n (%) | 34 (72.3) |
Median duration of antiretroviral treatment (months) (IQR) | 17.5 (4–32.5) |
Tuberculosis and anti-TB treatment | |
Multidrug-resistant TB (MDR-TB), n (%) | 44 (93.6) |
Extensively and extremely drug-resistant TB (XDR & XXDR-TB), n (%) | 3 (6.4) |
Extra-pulmonary TB | 14 (29.8) |
Median duration of anti-TB treatment (months) (IQR) | 13 (4–21) |